Merck 2017 forecast reassuring; full-speed ahead with Keytruda
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.75 -0.82 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.57 | 52 Week High | $77.12 | |||
| Open | $61.10 | 52 Week Low | $49.03 | |||
| Day High | $61.43 | P/E | 38.80 | |||
| Day Low | $59.54 | EPS | $1.54 | |||
| Volume | 13,778,562 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 145.95 +0.76 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.19 | 52 Week High | $65.46 | |||
| Open | $146.96 | 52 Week Low | $47.97 | |||
| Day High | $147.80 | P/E | 99.29 | |||
| Day Low | $145.61 | EPS | $1.47 | |||
| Volume | 11,242,159 | |||||
